HCPCS code J1305 — Inj, evinacumab-dgnb, 5mg.
Status: Active.
Effective Oct 1, 2021.
Source: CMS HCPCS Level II.
J1305
ActiveInj, evinacumab-dgnb, 5mg
Injection, evinacumab-dgnb, 5mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Oct 1, 2021
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9416
MUE — Medically Unlikely Edits
Maximum units of J1305 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 480 |
| Practitioner Services | 480 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 61755-0010-01 | Evkeeza |
| 61755-0013-01 | Evkeeza |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2021-Q4Inj, evinacumab-dgnb, 5mg